January 2026
The global oral clinical nutrition market size is calculated at USD 18.76 billion in 2025 and is projected to hit around USD 31.61 billion by 2035 with a CAGR of 5.36%.
September 2026
The global clinical nutrition market size is expected to increase from USD 35.93 billion in 2026 to hit around USD 57.34 billion by 2035, with a CAGR of 5.34%.
August 2025
The global adult clinical nutrition market size was estimated at USD 21.56 billion in 2024 and is expected to hit around USD 34.82 billion by 2034, growing at a CAGR of 4.91%.
September 2026
The preclinical CRO market size was valued at USD 7.29 billion in 2026 and is expected to hit around USD 14.01 billion by 2035, growing at a CAGR of 7.56%.
September 2026
The global clinical communication and collaboration market size was valued at USD 2.84 billion in 2026 and is projected to hit around USD 7.37 billion by 2035, expanding at a CAGR of 11.24%.
September 2026
The global oral mucositis treatment market size is estimated to hit around USD 3.96 billion by 2035 increasing from USD 2.13 billion in 2026, with a CAGR of 7.12%.
September 2026
The global behavioral rehabilitation market size accounted for USD 284.95 billion in 2026 and is expected to hit USD 455.48 billion by 2035, at a CAGR of 5.35%.
September 2026
The clinical laboratory service market size reached USD 334.25 billion in 2026, with leading clinical laboratory service market companies including Qiagen, Quest Diagnostics, Inc, OPKO Health, Inc.
September 2026
The mental health clinical trials market size was valued at USD 3.72 billion in 2026 and is projected to surge around USD 7.00 billion by 2034, with a CAGR of 8.24%.
September 2026
The clinical decision support systems market size is predicted to hit around USD 8.70 billion by 2035 from USD 4.28 billion in 2026 with a CAGR of 8.22%.
September 2026
The neurology clinical trials market size was valued at USD 6.57 billion in 2026 and is projected to reach around USD 10.14 billion by 2034 with a CAGR of 5.58%.
September 2026
The parenteral nutrition market size was USD 8.14 billion in 2026, with leading parenteral nutrition market players including Baxter, B. Braun Melsungen, Grifols, Otsuka Pharmaceutical Factory
September 2026
The global cognitive behavioral therapy market size is expected to attain around USD 34.04 billion by 2034 from USD 10.48 billion in 2026 with a CAGR of 15.96%.
September 2026
The global cardiovascular clinical trials market size was valued at USD 6.68 billion in 2026 and is expected to hit around USD 10.62 billion by 2034, growing at a CAGR of 5.98%.
September 2026
The global clinical documentation improvement market size is expected to hit around USD 10.44 billion by 2034 from USD 5.68 billion in 2026 with a CAGR of 7.90%.
September 2026
The global oral care products dental consumables market size is estimated to hit around USD 66.46 billion by 2035 increasing from USD 70.55 billion in 2026, with a CAGR of 6.14%.
September 2026
The U.S. behavioral health market is projected to grow from USD 100.9 billion in 2026 to USD 174.78 billion by 2035, registering a CAGR of 6.31%.
September 2026
The global nutritional supplements market size is valued at USD 441.74 billion in 2026 and is expected to reach over USD 808.64 billion by 2035 at a CAGR of 6.95%, driven by health and immunity product demand.
September 2026
The global preclinical imaging market size reached USD 3.18 billion in 2026 and is projected to surpass around USD 4.63 billion by 2035, growing at a CAGR of 4.26%.
September 2026
The clinical data analytics solutions market size is valued at USD 5.79 billion in 2026 and is projected to hit around USD 10.42 billion by 2035 with a CAGR of 6.75%.
September 2026
The oral transmucosal drugs market size was valued at USD 41.82 billion in 2026 and is projected to attain around USD 70.37 billion by 2034 with a CAGR of 6.72%.
September 2026
The global oral obesity therapies market size was evaluated at USD 4.70 billion in 2026 and is predicted to hit around USD 9.34 billion by 2035, growing at a CAGR of 7.94%.
September 2026
The global clinical AI model governance market size was evaluated at USD 2.58 billion in 2026 and is predicted to hit around USD 55.00 billion by 2035, growing at a CAGR of 40.46%.
September 2026
The global behavioral health market size was calculated at USD 197.34 billion in 2026 and is expected to hit around USD 349.88 billion by 2035 with a notable CAGR of 6.58%.
September 2026
The global clinical trials market size is calculated at USD 91.66 billion in 2026 and is projected to hit around USD 158.92 billion by 2035, with a solid CAGR of 6.15%.
September 2026
The global oncology clinical trials market size is expected to worth around USD 22.76 billion by 2034 from USD 13.60 billion in 2024 with a CAGR of 5.28%.
September 2026
The U.S. clinical trial management system market size was evaluated at USD 910 million in 2026 and is predicted to hit around USD 2,400 million by 2034, growing at a CAGR of 12.79%.
September 2026
The biopharma clinical trials market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries.
September 2026
The generative AI in clinical trials market size was USD 303.39 billion in 2026, with leading generative AI in clinical trials market players including IBM, Microsoft, Google Health, IQVIA, Parexel, ICON plc.
September 2026
The non-clinical information systems market reached USD 19.69 billion in 2026, with key non-clinical information systems market companies including Cerner Corporation, Allscripts Healthcare Solutions, Inc., McKesson Corporation, Epic Systems Corporation.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com